Search clinical trials for: Anagliptin BID Treatment

Total 15070 results

Long Min,MD

Unknown

Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers (DPP4i)

Diabetic Foot Ulcer

China
Boehringer Ingelheim
Eli Lilly and Company

Completed

MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

Diabetes Mellitus, Type 2

Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam
Fourth People's Hospital of Shenyang

Completed

The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Diabetes Mellitus, Type 2
Boehringer Ingelheim

Completed

Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single Tablets

Healthy

Germany
Fayoum University
Boehringer Ingelheim

Completed

Contrast Nephropathy in Type 2 Diabetes (VCG4)

Diabetes | Microalbuminuria | Kidney Function Affection Upon Exposure to Radiocontrast

Egypt
Shanghai Zhongshan Hospital
Chinese Medical Association

Completed

Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

China
Mundipharma Research Limited

Completed

Flutiform® Compared With Seretide® in the Treatment of COPD

Chronic Obstructive Pulmonary Disease

China, Taiwan, Korea, Republic of, New Zealand, Australia
Uppsala University

Completed

Survival After Surgical Treatment of Axis Fractures in Elderly

Spinal Fractures
Boehringer Ingelheim
Eli Lilly and Company

Completed

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Diabetes Mellitus, Type 2

United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
Biogen

Completed

New Formulation and Food Effect Study of BIIB074

Trigeminal Neuralgia (TN) | Other Neuropathic Pain

United States
Eisai Inc.

Completed

BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management

Obesity

United States
Lin Liao

Unknown

Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin

Type 2 Diabetes Mellitus

China
Pfizer

Completed

A Study Estimating The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

Healthy

Singapore
Biogen

Terminated

Study of Natalizumab in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
BDH-Klinik Hessisch Oldendorf

Recruiting

Influence of the Body Composition of Neurological (Early) Rehabilitants on Rehabilitation Success

Neurological Rehabilitation

Germany
Klinikum St. Georg gGmbH

Completed

Malnutrition Using GLIM Criteria and Comparing CT and BIA for Muscle Mass Measurement

Malnutrition
Samsung Medical Center

Completed

Bispectral Index Throughout Esophageal Cancer Operation

Esophageal Cancer

Korea, Republic of
Brainsway

Completed

Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.

Smoking Cessation

United States, Canada, Israel
yangjie

Completed

Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia (BPD)

Thrombocytopenia | Bronchopulmonary Dysplasia | Preterm Infant

China
Iyad Naeem Muhammad, PhD

Completed

Eradication of H. Pylori Infection With Moxifloxacin (RCT)

Helicobacter Pylori Infection | Helicobacter Pylori Infection, Susceptibility to

Pakistan
Karolinska Institutet
Karolinska University Hospital; Umeå University; Leiden University; Dalarna University and other collaborators

Recruiting

Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs (BESTa)

Neoplasm, Breast | Neoplasm, Colorectal | Neoplasm, Ovarian

Sweden
GID BIO, Inc.

Not yet recruiting

Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)

Erectile Dysfunction

United States
Education University of Hong Kong
Chinese University of Hong Kong

Completed

Efficacy of Amplification With Hearing Aids for Tinnitus Relief

Tinnitus, Subjective | Hearing Impairment

Hong Kong
Stanford University

Not yet recruiting

Examining Bluetooth Haptic Device Use for Pain and Anxiety Reduction in Vascular Access Procedures (VA+BHD)

Pain | Anxiety
Biocad

Recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma (OCTAVA)

Melanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma Metastatic | Melanoma Unresectable | Melanoma Advanced

India, Russian Federation, Belarus
KU Leuven
Universitaire Ziekenhuizen KU Leuven

Recruiting

Locomotor Muscle Oxygenation and Activation During Acute Interval Compared to Constant-load Bed-cycling Exercise

Critical Illness | Intensive Care Unit Acquired Weakness

Belgium
Biocad

Active, not recruiting

Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma (OBERTON)

Melanoma | Melanoma Metastatic

Russian Federation, Belarus
Science and Research Centre Koper
University of Trieste; University of Padova; University of Pavia; University of... and other collaborators

Completed

Biological and Functional Markers for Precision Astronautical Biomedicine (MARS-PRE)

Muscular Atrophy

Slovenia
US Department of Veterans Affairs
University of Washington

Completed

The Hearing Aid Effectiveness After Aural Rehabilitation (HEAR) Trial

Hearing Loss

United States
University of Manitoba

Completed

EEG, Cerebral Oximetry, and Arterial to Jugular Venous Lactate to Assess Cerebral Ischemia During Carotid Endarterectomy

Internal Carotid Artery Stenosis

Canada
JW Pharmaceutical

Active, not recruiting

Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM (SSUG)

Type 2 Diabetes Mellitus

Korea, Republic of
Agency for Healthcare Research and Quality (AHRQ)

Completed

Shared Decision-Making for Colorectal Cancer Screening

Colorectal Cancer

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Effect and Mechanism of Social Interaction Treatment on ASD Children

ASD
Alexion Pharmaceuticals
Parexel

Completed

Bioequivalence Between 180 mg and 60 mg ALXN2050 Tablets and Food Effect on ALXN2050 Pharmacokinetics

Healthy Adult Participants

United States
vTv Therapeutics

Not yet recruiting

Cadisegliatin as Adjunctive Therapy in Type 1 Diabetes (CATT1)

Diabetes Mellitus, Type 1
Pinnacle Clinical Research, PLLC

Completed

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

Fatty Liver | Fibrosis, Liver | Compensated Cirrhosis | Non-alcoholic Steatohepatitis

United States
Takeda

Completed

A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea

Type 2 Diabetes Mellitus

Korea, Republic of
Rabin Medical Center

Terminated

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Glucose Metabolism Disorders | Respiratory Tract Diseases | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | COVID 19 | Coronavirus | Metabolic Disease | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2 | Hormones | Hypoglycemic Agents | Incretins | Dipeptidyl-Peptidase IV Inhibitors and other conditions

Israel
Takeda

Completed

An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

Diabetes Mellitus

Russian Federation
Assistance Publique - Hôpitaux de Paris

Completed

ACute and Chronic Effects of Saxagliptin (ACCES)

Impaired Glucose Tolerance

France
University of Thessaly

Recruiting

The Impact of the Implementation of BIS on the Incidence of Postoperative Delirium

Postoperative Delirium

Greece
St. Joseph's Healthcare Hamilton

Completed

Brief Intervention and Contact (BIC) Program (BIC)

Suicidal Behavior

Canada
Mahidol University

Completed

BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients (BEDTIME)

Renal Failure Chronic Requiring Hemodialysis | Poor Quality Sleep

Thailand
Medtronic Neurovascular Clinical Affairs

Recruiting

Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma (EMBOLISE)

Subdural Hematoma

United States
Oslo University Hospital

Terminated

Hyperbaric Oxygen Treatment as Adjuvant Treatment for Frost Injury (FROST)

Wound (Morphologic Abnormality)

Norway
EMS

Not yet recruiting

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

Type 2 Diabetes Mellitus
University of Pisa

Completed

Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.

Type2 Diabetes Mellitus

Italy
Boehringer Ingelheim
Eli Lilly and Company

Completed

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Japan

Search clinical trials for: Anagliptin BID Treatment

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations